<p>Touyun Biotech Group Limited has announced that its wholly-owned subsidiary, Shanxi Touyun Biotechnology Co., Ltd., entered into a loan agreement with a lender for a principal amount of RMB90 million, with a maturity date of 11 December 2025. As of the maturity date, the Borrower had not repaid the loan. Including a previously disclosed overdue loan of RMB60 million, the total outstanding loans payable to the lender amount to RMB150 million. The Group is currently in negotiations with the lender regarding partial repayment and a possible extension of the repayment date. The company has stated that non-payment of the outstanding loans could negatively impact its operations and will provide further updates as necessary. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Touyun Biotech Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952926), on December 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

01332

<p>Touyun Biotech Group Fails to Repay RMB150 Million Loan and Seeks Extension</p>